kidney disease Archives
Improved imaging for kidney disease
May. 8, 2023—Vanderbilt researchers identified optimal MRI parameters for estimating the severity of polycystic kidney disease, a common inherited disorder that can lead to end-stage renal failure.
VUMC researchers upend dogma about vasopressin production
Jan. 5, 2023—Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.
Novel therapeutic target identified for chronic kidney disease
Dec. 15, 2022—Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.
Nephrology society lauds Bock’s research on kidney development
Dec. 15, 2022—Vanderbilt's Fabian Bock, MD, PhD, won two awards at the Basic Research Forum for Emerging Kidney Scientists, presented virtually by the American Society of Nephrology and American Physiological Society.
Terker selected as VUMC Discovery Scholar in Health and Medicine
Oct. 27, 2022— by Bill Snyder Andrew Terker, MD, PhD, assistant professor of Medicine in the Division of Nephrology and Hypertension at Vanderbilt University Medical Center, has been selected as the 2022 VUMC Discovery Scholar in Health and Medicine. The Discovery Scholars program was launched in 2020 with funding from the Brock Family Directorship in Career Development...
Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage
Oct. 20, 2022—by Bill Snyder Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage. Their findings, featured Oct. 14 on the cover of Circulation Research, suggest that targeting inflammatory cytokines, signaling...
Study sheds light on the dark side of obesity
May. 12, 2022—Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity.
VUMC study raises hope for improving treatment of kidney disease
Feb. 2, 2022—Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.
Accelerating podocyte production
Feb. 1, 2022—A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.
Harrison Society researcher discovers key regulator of kidney cell structure
Nov. 4, 2021—New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs.
Gene expression in diabetic nephropathy
Aug. 5, 2021—Vanderbilt researchers are looking to mRNA populations in podocytes — kidney cells that help filter blood — to help identify potential targets for treating diabetic kidney disease.
Spirituality may help reduce end-stage kidney disease risk
Mar. 25, 2021—Researchers from Vanderbilt’s Division of Nephrology and Hypertension have identified an under-studied characteristic that may have a protective effect on end-stage kidney disease (ESKD) risk among vulnerable populations.